Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models

Journal of Alzheimer's Disease : JAD
Larry Baum, Alex Ng

Abstract

Curcumin is a polyphenolic diketone from turmeric. Because of its anti-oxidant and anti-inflammatory effects, it was tested in animal models of Alzheimer's disease, reducing levels of amyloid and oxidized proteins and preventing cognitive deficits. An alternative mechanism of these effects is metal chelation, which may reduce amyloid aggregation or oxidative neurotoxicity. Metals can induce Abeta aggregation and toxicity, and are concentrated in AD brain. Chelators desferrioxamine and clioquinol have exhibited anti-AD effects. Using spectrophotometry, we quantified curcumin affinity for copper, zinc, and iron ions. Zn2+ showed little binding, but each Cu2+ or Fe2+ ion appeared to bind at least two curcumin molecules. The interaction of curcumin with copper reached half-maximum at approximately 3-12 microM copper and exhibited positive cooperativity, with Kd1 approximately 10-60 microM and Kd2 approximately 1.3 microM (for binding of the first and second curcumin molecules, respectively). Curcumin-iron interaction reached half-maximum at approximately 2.5-5 microM iron and exhibited negative cooperativity, with Kd1 approximately 0.5-1.6 microM and Kd2 approximately 50-100 microM. Curcumin and its metabolites can attain these lev...Continue Reading

Citations

Jan 8, 2020·Antimicrobial Agents and Chemotherapy·Derek C K ChanLori L Burrows
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hani Atamna, Kathleen Boyle
Apr 25, 2007·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Hila ShovalEhud Gazit
Jan 15, 2008·Acta Neuropathologica·Neeraj PandeyJames E Galvin
Jul 25, 2008·International Journal of Food Sciences and Nutrition·Siriporn TuntipopipatSomsri Charoenkiatkul
May 22, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Donald J MessnerKris V Kowdley
Oct 1, 2006·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Greg M Cole, Sally A Frautschy
Apr 28, 2010·Expert Review of Neurotherapeutics·Altaf S DarveshCornelis J Van der Schyf
Oct 26, 2011·Journal of Drug Targeting·Mohammad FazilJaved Ali
Oct 8, 2011·Natural Product Reports·Subash C GuptaBharat B Aggarwal
Jul 20, 2011·The British Journal of Nutrition·Martin Loef, Harald Walach
Sep 23, 2014·Archiv der Pharmazie·Joyce TrujilloJosé Pedraza-Chaverrí
Oct 30, 2016·Antioxidants·Nur Adalier, Heath Parker
Jun 18, 2017·Pharmacological Reports : PR·Agnieszka Wąsik, Lucyna Antkiewicz-Michaluk
Aug 5, 2018·Journal of Cellular Physiology·Mahdi HatamipourAmirhosein Sahebkar
Nov 9, 2018·Frontiers in Aging Neuroscience·Muhammad OvaisZabta Khan Shinwari
Aug 16, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Raghavendhar R Kotha, Devanand L Luthria
Jul 28, 2019·Journal of Cellular Physiology·Mahdi HatamipourAmirhossein Sahebkar
Nov 27, 2019·Journal of Evidence-based Integrative Medicine·Wycliffe ArikaMathew Piero Ngugi
Nov 14, 2007·Journal of Applied Genetics·Alfredo Corona-RiveraJorge Roman Corona-Rivera
Jul 17, 2010·Bioinorganic Chemistry and Applications·Bachar ZebibVirginie Noirot
Apr 6, 2012·Neurochemical Research·Han-Chang HuangZhao-Feng Jiang
Dec 4, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kavirayani Indira Priyadarsini
Apr 26, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rosaliana LibroEmanuela Mazzon
Aug 30, 2016·Chemical Biology & Drug Design·Erika FerrariKatarina Siposova
Jan 12, 2017·Journal of Cellular Physiology·Mahin RamezaniAmirhosein Sahebkar
Jan 28, 2017·Nutrition and Cancer·Donald J MessnerKris V Kowdley
May 21, 2016·Scientific Reports·Nelson FerreiraMaria R Almeida
May 31, 2017·Current Medicinal Chemistry·José TeixeiraPaulo J Oliveira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.